理解放射科医生在肝细胞癌患者复杂治疗决策中的作用
本文为综述,概述肝细胞癌的分期系统、治疗选择及资格标准,讨论影像在诊断、治疗计划与疗效监测中的意义,并强调放射科医生在多学科肿瘤委员会个体化治疗决策及疗效不佳时重新评估中的核心作用。
要点
- 放射科医生需了解肝细胞癌各治疗方案的适用与禁忌标准,以有效参与多学科肿瘤委员会。
- 影像在肝细胞癌诊断、治疗计划及疗效监测中具有关键作用。
- 治疗决策中依赖影像判读的关键分支点需放射科医生重点掌握。
核心结论
- 放射科医生应熟悉肝细胞癌治疗选择及个体化治疗计划的资格标准,从而在多学科肿瘤委员会中有效贡献,并在疗效评估不充分时于重新评估治疗计划中发挥核心作用。
研究设计与样本
- 综述,旨在为放射科医生提供肝细胞癌分期系统、治疗选择及资格标准的概述。
临床应用与阅片要点
- 放射科医生应了解肝细胞癌可用治疗类型及指导个体化治疗计划的资格标准。
- 放射科医生应在肝细胞癌多学科肿瘤委员会中以患者为中心有效参与。
- 当治疗反应评估为不充分时,放射科医生在重新评估治疗计划中发挥核心作用。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Hepatocellular carcinoma (HCC) is the most common primary malignant tumor of the liver and represents a significant global health burden. Management of HCC can be challenging due to multiple factors, including variable expectations for treatment outcomes. Several treatment options are available, each with specific eligibility and ineligibility criteria, and are provided by a multidisciplinary team of specialists. Radiologists should be aware of the types of treatment options available, as well as the criteria guiding the development of individualized treatment plans. This awareness enables radiologists to contribute effectively to patient-centered multidisciplinary tumor boards for HCC and play a central role in reassessing care plans when the treatment response is deemed inadequate. This comprehensive review aims to equip radiologists with an overview of HCC staging systems, treatment options, and eligibility criteria. The review also discusses the significance of imaging in HCC diagnosis, treatment planning, and monitoring treatment response. Furthermore, we highlight the crucial branch points in the treatment decision-making process that depend on radiological interpretation.
引用
- Kamal O, Horvat N, Arora S, et al. Understanding the role of radiologists in complex treatment decisions for patients with hepatocellular carcinoma. Abdom Radiol (NY). 2023. PMID: 37715846. doi:10.1007/s00261-023-04033-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。